What is the treatment for drug-induced obesity?
Drug-induced obesity is weight gain attributable to medication use. The first-line approach is a structured, intensive lifestyle intervention aimed at achieving clinically meaningful weight reduction and improving related metabolic outcomes.
Clinical Goals
A weight loss of 5–7% of baseline body weight improves glycemia and other intermediate cardiovascular risk factors. Sustained loss of more than 10% of body weight confers greater metabolic benefits, including possible remission of type 2 diabetes and improvements in long-term cardiovascular outcomes.
Treatment Approach
Management centres on an intensive, high-contact program combining nutrition guidance, structured physical activity, and behavioural strategies — targeting a sustained daily energy deficit. Session frequency and contact intensity are key components of the protocol.
The full regimen — including session frequency thresholds, specific energy-deficit targets, activity progression milestones, and the complete decision algorithm — is in the structured protocol below.
References
DOI: 10.2337/dc26-S008
- Nutrition, physical activity, and behavioral therapy are recommended for people with type 2 diabetes and overweight or obesity to achieve both weight and health outcome goals.
- Interventions including high frequency of counseling (≥16 sessions in 6 months) with focus on nutrition changes, physical activity, and behavioral strategies to achieve a 500–750 kcal/day energy deficit (irrespective of macronutrient composition) should be recommended for weight loss when available.
- Like all adults, people with overweight and obesity should be encouraged to do activities they enjoy, with an eventual goal of getting 150 min of physical activity per week.
- Weight loss of 5–7% of baseline weight improves glycemia and other intermediate cardiovascular risk factors.
- Sustained loss of >10% of body weight usually confers greater benefits, including disease-modifying effects and possible remission of type 2 diabetes and may improve long-term cardiovascular outcomes and mortality.
View source ↗